G01N 2333/70589
Cd45
G01N2333/70589 (Cd45) appears on 104 US grants and 225 published applications in this corpus.
Search patents in G01N- Granted patents
- 104
- Published applications
- 225
- Assignees
- 136
- Inventors
- 487
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 2 |
| 2003 | 0 | 4 |
| 2004 | 1 | 0 |
| 2005 | 0 | 2 |
| 2006 | 1 | 1 |
| 2007 | 1 | 9 |
| 2008 | 0 | 6 |
| 2009 | 1 | 2 |
| 2010 | 3 | 2 |
| 2011 | 2 | 7 |
| 2012 | 3 | 3 |
| 2013 | 2 | 6 |
| 2014 | 5 | 10 |
| 2015 | 3 | 15 |
| 2016 | 4 | 15 |
| 2017 | 5 | 23 |
| 2018 | 10 | 15 |
| 2019 | 5 | 10 |
| 2020 | 12 | 16 |
| 2021 | 10 | 12 |
| 2022 | 4 | 14 |
| 2023 | 4 | 14 |
| 2024 | 9 | 14 |
| 2025 | 7 | 17 |
| 2026 | 6 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Monoclonal antibody drug sensitivity in multiple myeloma patients6 Oct 2026US 12,754,180 B2The Regents of the University of Colorado, a body corporate
- Artificial intelligence for early cancer detection8 Sep 2026US 12,730,108 B2Regents of the University of Minnesota
- Methods and systems for detecting tissue conditions19 May 2026US 12,630,871 B2Superfluid Dx, Inc.
- Systems, methods and assays for outlier clustering unsupervised learning automated report (OCULAR)21 Apr 2026US 12,607,561 B2University of Southern California
- Detection of early-stage lung cancer in sputum using automated flow cytometry and machine learning3 Feb 2026US 12,542,215 B2bioAffinity Technologies, Inc.
- Method and treatment9 Jul 2026US 2026/0194526 A1
- System, method, and article for detecting abnormal cells using multi-dimensional analysis21 May 2026US 2026/0140119 A1HematoLogics, Inc.
- Control cell populations for detection of paroxysmal nocturnal hemoglobinuria14 May 2026US 2026/0133112 A1Biolegend, Inc.
- Use of extracellular vesicles and micronuclei of circulating stromal cells as pan-cancer biomarkers for predicting clinical outcomes12 Mar 2026US 2026/0072033 A1Creatv MicroTech, Inc.
- Combination therapy with anti-pvrig antibodies formulations and anti-pd-1 antibodies5 Feb 2026US 2026/0035460 A1Bristol-Myers Squibb Company
Most cited
By later US patents
- Apparatus and methods for magnetic separation265US 5,200,084 AImmunicon Corporation · 1993
- Microfluidic device for cell separation and uses thereof147US 8,304,230 B2The General Hospital Corporation · 2012
- Microfluidic device for cell separation and uses thereof111US 8,372,579 B2The General Hospital Corporation · 2013
- Methods and devices for manipulation of magnetically collected material105US 5,622,831 AImmunivest Corporation · 1997
- Assay implementation in a microfluidic format74US 7,553,453 B2Honeywell International Inc. · 2009